ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 173 filers reported holding ACCELERON PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $172,100,000 | -2.0% | 1,000,000 | -28.6% | 3.85% | +8.0% |
Q2 2021 | $175,686,000 | -7.5% | 1,400,000 | 0.0% | 3.57% | +6.3% |
Q1 2021 | $189,854,000 | +6.0% | 1,400,000 | 0.0% | 3.36% | -12.7% |
Q4 2020 | $179,116,000 | +13.7% | 1,400,000 | 0.0% | 3.84% | +0.5% |
Q3 2020 | $157,542,000 | +18.1% | 1,400,000 | 0.0% | 3.82% | +2.5% |
Q2 2020 | $133,378,000 | -1.1% | 1,400,000 | -6.7% | 3.73% | -34.5% |
Q1 2020 | $134,805,000 | +111.9% | 1,500,000 | +25.0% | 5.70% | +131.8% |
Q4 2019 | $63,624,000 | +7.4% | 1,200,000 | -20.0% | 2.46% | +3.5% |
Q3 2019 | $59,265,000 | -3.8% | 1,500,000 | 0.0% | 2.38% | -4.7% |
Q2 2019 | $61,620,000 | -28.5% | 1,500,000 | -18.9% | 2.49% | -29.2% |
Q1 2019 | $86,155,000 | +58.3% | 1,850,000 | +48.0% | 3.52% | +74.4% |
Q4 2018 | $54,438,000 | -4.9% | 1,250,000 | +25.0% | 2.02% | +35.5% |
Q3 2018 | $57,230,000 | +7.2% | 1,000,000 | -9.1% | 1.49% | +31.3% |
Q2 2018 | $53,372,000 | +60.6% | 1,100,000 | +29.4% | 1.13% | +172.6% |
Q1 2018 | $33,235,000 | +4.4% | 850,000 | +13.3% | 0.42% | -13.3% |
Q4 2017 | $31,830,000 | +21.8% | 750,000 | +7.1% | 0.48% | +6.7% |
Q3 2017 | $26,124,000 | +22.8% | 700,000 | 0.0% | 0.45% | +21.0% |
Q2 2017 | $21,273,000 | +7.2% | 700,000 | -6.7% | 0.37% | -15.6% |
Q1 2017 | $19,853,000 | +418.6% | 750,000 | +400.0% | 0.44% | +418.8% |
Q4 2016 | $3,828,000 | -39.6% | 150,000 | -14.3% | 0.08% | -32.0% |
Q3 2016 | $6,333,000 | +86.4% | 175,000 | +75.0% | 0.12% | +78.6% |
Q2 2016 | $3,398,000 | – | 100,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |